Therapeutic effectiveness of liver transplantation: A single center study of 203 consecutive cases

National Medical Journal of China

Volumn 85, Issue 26, 2005, Pages 1805-1808

  Zhou, Jian ^a   Fan, Jia ^a   Wu, Zhi Quan ^a   Qiu, Shuang Jian ^a   Wang, Zheng ^a   Huang, Xiao Wu ^a   Yu, Yao ^a   He, Yi Feng ^a   Tang, Zhao You ^a   Wang, Yu Qi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Liver transplantation; Therapy; Transplantation, homologous

Indexed keywords

TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER DONOR; CHILD; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TUMOR THROMBUS; TUMOR VOLUME; WILSON DISEASE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 22744458336     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg, 2000, 191: 389-394.
2. Pomfret EA. What is the quality-of-life after live liver donation? Am J Transplant, 2004, 4: 673-674.
3. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002. 81-84.
4. Starzl TE, Iwatsuki S, Esquivel CO, et al. Refinements in the surgical technique of liver transplantation. Semin Liver Dis, 1985, 5: 349-356.
5. Valentin-Gamazo C, Malago M, Karliova M, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl, 2004, 10: 1087-1096.
6. Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers, Transplantation, 2003, 75 Suppl 3: S12-S15.
7. Ho BM, So SK, Esquivel CO, et al. Liver transplantation in Asian patients with chronic hepatitis B. Hepatology, 1997, 25: 223-225.
8. Schumacher G, Platz KP, Mueller AR, et al. Liver transplantation in neurologic Wilson disease. Transplant Proc, 2001, 33: 1518-1519.
9. Yao FY, Roberts JP. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: toe much too soon, or is now the time? Liver Transpl, 2004, 10: 919-921.
10. Song SB, Zhang TL, Xiu DR. Effective evaluation of liver transplantation for hepatocellular carcinoma. Natl Med J China, 2004,84:1533-1535.
11. Zhang TL. Therapy value of liver transplantation for late stage liver cancer. Natl Med J China, 2004, 84: 1499-1500.
12. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Traspl, 2002, 8: 765-774.
13. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology, 1998, 27: 1572-1577.
14. Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer, 2000, 88: 538-543.
15. Olthoff KM, Rosove MH, Shackleton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma Ann Surg, 1995, 221: 734-741.
16. Guba M, Breitenbuch PV, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nature Med, 2002, 8: 128-135.